Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceutical...
FDA Drug Recall #D-1309-2019 — Class I — May 11, 2019
Recall Summary
| Recall Number | D-1309-2019 |
| Classification | Class I — Serious risk |
| Date Initiated | May 11, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Novartis Pharmaceuticals Corp. |
| Location | East Hanover, NJ |
| Product Type | Drugs |
| Quantity | 792 cartons |
Product Description
Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.
Reason for Recall
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Distribution Pattern
Nationwide with in the United States
Lot / Code Information
Lot #: 8H57901589, Exp. 09/2020; 9H57900189 and 9H57900289, Exp. 12/2020.
Other Recalls from Novartis Pharmaceuticals Corp.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-1174-2023 | Class I | SANDIMMUNE Oral Solution (cyclosporine oral sol... | Sep 8, 2023 |
| D-0678-2017 | Class III | Isopto Carpine (pilocarpine hydrochloride optha... | Mar 22, 2017 |
| D-0679-2017 | Class III | Pilocarpine Hydrochloride Ophthalmic Solution 4... | Mar 22, 2017 |
| D-1430-2015 | Class III | Dexmethylphenidate HCl Extended-Release, Capsul... | Jul 28, 2015 |
| D-1138-2015 | Class III | Foradil Aerolizer (formoterol fumarate inhalati... | May 22, 2015 |
Frequently Asked Questions
Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.